Merck KGaA Eyes 20% Sales Growth In India Over Next Three Years
This article was originally published in PharmAsia News
Executive Summary
Germany’s Merck KGaA says it is planning for a growth of at least 20% in India sales over the next three years due to launches of drugs aimed at women’s healthcare, diabetes and cardiovascular treatment.